FDA Approves New Restless Legs Syndrome Drug Horizant

The FDA has approved a new drug called Horizant to treat moderate-to-severe restless legs syndrome.

Click here to read the full story.

Post a Comment

No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.